{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 7658, "items": [{"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T10:33:11Z", "timestamp": 1574332391294}, "reference-count": 0, "publisher": "Physicians Postgraduate Press, Inc", "issue": "10", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Clin. Psychiatry"], "published-print": {"date-parts": [[2009, 10, 15]]}, "DOI": "10.4088/jcp.09m05133blu", "type": "journal-article", "created": {"date-parts": [[2009, 10, 30]], "date-time": "2009-10-30T20:01:18Z", "timestamp": 1256932878000}, "page": "1365-1371", "source": "Crossref", "is-referenced-by-count": 25, "title": ["Assessing the Efficacy of Desvenlafaxine for Improving Functioning and Well-Being Outcome Measures in Patients With Major Depressive Disorder"], "prefix": "10.4088", "volume": "70", "author": [{"given": "Claudio N.", "family": "Soares", "sequence": "first", "affiliation": []}, {"given": "Susan G.", "family": "Kornstein", "sequence": "additional", "affiliation": []}, {"given": "Michael E.", "family": "Thase", "sequence": "additional", "affiliation": []}, {"given": "Qin", "family": "Jiang", "sequence": "additional", "affiliation": []}, {"given": "Christine J.", "family": "Guico-Pabia", "sequence": "additional", "affiliation": []}], "member": "2558", "container-title": ["The Journal of Clinical Psychiatry"], "deposited": {"date-parts": [[2009, 10, 30]], "date-time": "2009-10-30T20:01:23Z", "timestamp": 1256932883000}, "score": 111.017105, "subtitle": ["A Pooled Analysis of 9 Double-Blind, Placebo-Controlled, 8-Week Clinical Trials"], "issued": {"date-parts": [[2009, 10, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2009, 10, 15]]}, "issue": "10"}, "URL": "http://dx.doi.org/10.4088/jcp.09m05133blu", "ISSN": ["0160-6689"], "issn-type": [{"value": "0160-6689", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T13:03:38Z", "timestamp": 1574427818718}, "reference-count": 28, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Clinical Psychopharmacology"], "published-print": {"date-parts": [[2010, 6]]}, "DOI": "10.1097/jcp.0b013e3181dcb594", "type": "journal-article", "created": {"date-parts": [[2010, 5, 5]], "date-time": "2010-05-05T08:28:32Z", "timestamp": 1273048112000}, "page": "294-299", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Analysis by Age and Sex of Efficacy Data From Placebo-Controlled Trials of Desvenlafaxine in Outpatients With Major Depressive Disorder"], "prefix": "10.1097", "volume": "30", "author": [{"given": "Susan G.", "family": "Kornstein", "sequence": "first", "affiliation": []}, {"given": "Anita H.", "family": "Clayton", "sequence": "additional", "affiliation": []}, {"given": "Claudio N.", "family": "Soares", "sequence": "additional", "affiliation": []}, {"given": "Sudharshan K.", "family": "Padmanabhan", "sequence": "additional", "affiliation": []}, {"given": "Christine J.", "family": "Guico-Pabia", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Journal of Clinical Psychopharmacology"], "language": "en", "deposited": {"date-parts": [[2019, 2, 28]], "date-time": "2019-02-28T12:17:26Z", "timestamp": 1551356246000}, "score": 53.63652, "subtitle": [""], "issued": {"date-parts": [[2010, 6]]}, "references-count": 28, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.1097/jcp.0b013e3181dcb594", "ISSN": ["0271-0749"], "issn-type": [{"value": "0271-0749", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T09:17:34Z", "timestamp": 1575451054022}, "reference-count": 44, "publisher": "Cambridge University Press (CUP)", "license": [{"URL": "https://www.cambridge.org/core/terms", "start": {"date-parts": [[2019, 5, 7]], "date-time": "2019-05-07T00:00:00Z", "timestamp": 1557187200000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CNS Spectr."], "abstract": "<jats:sec id=\"S1092852919000828_as1\"><jats:title>Objective</jats:title><jats:p>The value of early functional improvement at week 2 for predicting subsequent functional outcomes at week 8 was assessed in a pooled analysis of patients with major depressive disorder (MDD) treated with desvenlafaxine (50 or 100\u00a0mg/d) or placebo.</jats:p></jats:sec><jats:sec id=\"S1092852919000828_as2\" sec-type=\"methods\"><jats:title>Methods</jats:title><jats:p>Data were pooled from eight double-blind, placebo-controlled studies of desvenlafaxine 50\u00a0mg/d or 100\u00a0mg/d for the treatment of MDD. Optimal week-2 improvement thresholds in Sheehan Disability Scale (SDS) score, which best predicted week-8 treatment success, were determined using receiver operating characteristic (ROC) analysis. Four definitions of treatment success were established: (1) functional response, (2) functional/depression response, (3) functional remission, and (4) functional/depression remission. Odds ratios (ORs) of early improvement for prediction (based on thresholds determined in the ROC analysis) of week-8 treatment success were computed using logistic regression models.</jats:p></jats:sec><jats:sec id=\"S1092852919000828_as3\" sec-type=\"results\"><jats:title>Results</jats:title><jats:p>Functional early improvement thresholds of 17%\u201332% were predictive of week-8 treatment success across treatment groups and definitions of treatment success. Optimal thresholds were higher for more stringent definitions. Negative predictive value exceeded positive predictive value, indicating that failure to achieve early functional improvement was more informative about later treatment success than was the achievement of early functional improvement. Early change in SDS was a highly significant predictor of functional response/remission (ORs, 4.981\u20138.737; all <jats:italic>p</jats:italic> &amp;lt; 0.0001); the interaction between treatment and early functional improvement was not significant.</jats:p></jats:sec><jats:sec id=\"S1092852919000828_as4\"><jats:title>Conclusion</jats:title><jats:p>Early improvement in SDS total score was predictive of functional outcomes for patients treated with desvenlafaxine 50\u00a0mg, desvenlafaxine 100\u00a0mg, or placebo.</jats:p></jats:sec>", "DOI": "10.1017/s1092852919000828", "type": "journal-article", "created": {"date-parts": [[2019, 5, 7]], "date-time": "2019-05-07T08:04:05Z", "timestamp": 1557216245000}, "page": "1-9", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Predictors of functional response and remission with desvenlafaxine 50 mg and 100 mg: a pooled analysis of randomized, placebo-controlled studies in patients with major depressive disorder"], "prefix": "10.1017", "author": [{"ORCID": "http://orcid.org/0000-0001-7056-7174", "authenticated-orcid": false, "given": "Claudio N.", "family": "Soares", "sequence": "first", "affiliation": []}, {"given": "Dalia B.", "family": "Wajsbrot", "sequence": "additional", "affiliation": []}, {"given": "Matthieu", "family": "Boucher", "sequence": "additional", "affiliation": []}], "member": "56", "published-online": {"date-parts": [[2019, 5, 7]]}, "reference": [{"key": "S1092852919000828_ref39", "DOI": "10.1016/0893-133X(95)00272-F", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref38", "DOI": "10.1017/S1092852900020125", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref9", "DOI": "10.1185/030079906X132415", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref8", "DOI": "10.1093/ijnp/pyx081", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref7", "author": "Habert", "volume": "18", "year": "2016", "journal-title": "Prim Care Companion CNS Disord"}, {"key": "S1092852919000828_ref36", "author": "Gorwood", "volume": "11", "first-page": "2875", "year": "2015", "journal-title": "Neuropsychiatr Dis Treat"}, {"key": "S1092852919000828_ref6", "DOI": "10.1177/0706743716659416", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref35", "author": "Gallop", "first-page": "777", "year": "2001", "volume-title": "Proceedings of the NorthEast SAS Users Group"}, {"key": "S1092852919000828_ref34", "DOI": "10.1097/YIC.0b013e3282f2b4d6", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref4", "first-page": "155", "year": "2013", "volume-title": "Diagnostic and Statistical Manual of Mental Disorders"}, {"key": "S1092852919000828_ref33", "DOI": "10.1097/YIC.0b013e328341bb5f", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref3", "DOI": "10.2165/11530230-000000000-00000", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref32", "DOI": "10.1192/bjp.134.4.382", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref31", "year": "2000", "volume-title": "Diagnostic and Statistical Manual of Mental Disorders, Text Revision"}, {"key": "S1092852919000828_ref30", "year": "1994", "volume-title": "Diagnostic and Statistical Manual of Mental Disorders"}, {"key": "S1092852919000828_ref29", "DOI": "10.1136/jnnp.23.1.56", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref28", "DOI": "10.1186/1471-244X-13-94", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref27", "author": "Sheehan", "first-page": "113", "year": "2000", "volume-title": "Handbook of Psychiatric Measures"}, {"key": "S1092852919000828_ref26", "DOI": "10.1097/YIC.0000000000000031", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref25", "DOI": "10.1017/S1092852914000066", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref24", "DOI": "10.1097/JCP.0b013e31822c0a68", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref23", "DOI": "10.4088/JCP.12m08065", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref22", "DOI": "10.1097/01.pra.0000426323.59698.64", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref21", "DOI": "10.1016/j.clinthera.2009.07.006", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref20", "DOI": "10.1097/YIC.0b013e32830cebed", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref19", "DOI": "10.1185/03007990802161923", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref18", "DOI": "10.4088/JCP.v68n0504", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref17", "DOI": "10.1097/JCP.0000000000000049", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref48", "DOI": "10.1007/s40263-014-0171-5", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref16", "DOI": "10.1177/0706743716659417", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref47", "author": "Henssler", "volume": "79", "year": "2018", "journal-title": "J Clin Psychiatry"}, {"key": "S1092852919000828_ref15", "DOI": "10.1038/mp.2012.33", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref46", "author": "Henssler", "volume": "79", "year": "2018", "journal-title": "J Clin Psychiatry"}, {"key": "S1092852919000828_ref14", "DOI": "10.1016/j.jad.2013.10.002", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref45", "DOI": "10.1016/j.jad.2016.02.039", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref13", "DOI": "10.1016/j.jad.2012.07.008", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref44", "DOI": "10.1016/j.jpsychires.2007.10.004", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref12", "DOI": "10.1111/j.1440-1819.2010.02091.x", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref43", "DOI": "10.4088/JCP.v68n0805", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref11", "DOI": "10.1016/S0165-0327(98)00133-5", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref42", "DOI": "10.4088/JCP.v66n0201", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref10", "DOI": "10.1176/ajp.2006.163.11.1905", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref41", "DOI": "10.4088/JCP.v62n0509", "doi-asserted-by": "publisher"}, {"key": "S1092852919000828_ref40", "DOI": "10.1001/archpsyc.55.4.334", "doi-asserted-by": "publisher"}], "container-title": ["CNS Spectrums"], "language": "en", "link": [{"URL": "https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S1092852919000828", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 7]], "date-time": "2019-05-07T08:55:40Z", "timestamp": 1557219340000}, "score": 51.328964, "issued": {"date-parts": [[2019, 5, 7]]}, "references-count": 44, "URL": "http://dx.doi.org/10.1017/s1092852919000828", "relation": {"cites": []}, "ISSN": ["1092-8529", "2165-6509"], "issn-type": [{"value": "1092-8529", "type": "print"}, {"value": "2165-6509", "type": "electronic"}], "subject": ["Psychiatry and Mental health", "Clinical Neurology"]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T18:20:38Z", "timestamp": 1575310838590}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2008, 8, 1]], "date-time": "2008-08-01T00:00:00Z", "timestamp": 1217548800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Neuropsychopharmacology"], "published-print": {"date-parts": [[2008, 8]]}, "DOI": "10.1016/s0924-977x(08)70478-4", "type": "journal-article", "created": {"date-parts": [[2008, 10, 2]], "date-time": "2008-10-02T09:24:35Z", "timestamp": 1222939475000}, "page": "S342-S343", "source": "Crossref", "is-referenced-by-count": 0, "title": ["P.2.c.033 The efficacy of desvenlafaxine for improving functioning and quality of life measures in patients with major depressive disorder"], "prefix": "10.1016", "volume": "18", "author": [{"given": "C.", "family": "Soares", "sequence": "first", "affiliation": []}, {"given": "M.", "family": "Thase", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Kornstein", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Brisard", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Septien-Velez", "sequence": "additional", "affiliation": []}, {"given": "J.M.", "family": "Germain", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Pitrosky", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Patroneva", "sequence": "additional", "affiliation": []}, {"given": "Q.", "family": "Jiang", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Ninan", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Ganguly", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Neuropsychopharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0924977X08704784?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0924977X08704784?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 25]], "date-time": "2018-12-25T09:52:25Z", "timestamp": 1545731545000}, "score": 49.086273, "issued": {"date-parts": [[2008, 8]]}, "references-count": 0, "alternative-id": ["S0924977X08704784"], "URL": "http://dx.doi.org/10.1016/s0924-977x(08)70478-4", "ISSN": ["0924-977X"], "issn-type": [{"value": "0924-977X", "type": "print"}], "subject": ["Pharmacology (medical)", "Biological Psychiatry", "Pharmacology", "Neurology", "Psychiatry and Mental health", "Clinical Neurology"]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T15:33:51Z", "timestamp": 1574782431636}, "reference-count": 0, "publisher": "Hindawi Limited", "issue": "7", "license": [{"URL": "http://creativecommons.org/licenses/by-nc/4.0/", "start": {"date-parts": [[1990, 1, 1]], "date-time": "1990-01-01T00:00:00Z", "timestamp": 631152000000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Canadian Journal of Gastroenterology"], "published-print": {"date-parts": [[1990]]}, "abstract": "<jats:p>The efficacy and tolerance of 500 mg 5-aminosalicylic acid (mesalamine) suppositories in the treatment of ulcerative proctitis were assessed in two double-blind, placebo controlled studies of six weeks' duration, involving a total of 173 patients. In trial 1, patients used one 500 mg suppository tid. In trial 2, patients used one 500 mg suppository bid. Physician's global assessment and a disease activity index based upon patient symptoms and sigmoidoscopic appearance were used to assess efficacy. At the endpoint of trial l (tid), there was an 80.4% mean reduction in the disease activity index seen in patients treated with mesalamine compared to a 36.8% mean reduction in the placebo group (P&lt;0.05). Analysis of the physician's global assessment indicated that 84.2% of patients receiving mesalamine were considered to be 'much improved' compared to 41 % of patients on placebo (P&lt;0.01). At the endpoint of trial 2 (tid), there was a 74.7% mean reduction in disease activity index compared to 34.2% in the placebo group (P&lt;0.001). Analysis of the physician's global assessment indicated that 79.2% of the mesalamine group was considered to be 'much improved' compared to 26.2% on placebo (P&lt;0.001). There was no significant difference in efficacy seen in patients treated with 500 mg mesalamine suppositories bid or tid. Mesalamine suppositories are effective and well tolerated in the treatment of ulcerative proctitis.</jats:p>", "DOI": "10.1155/1990/689834", "type": "journal-article", "created": {"date-parts": [[2016, 4, 5]], "date-time": "2016-04-05T21:01:56Z", "timestamp": 1459890116000}, "page": "472-475", "source": "Crossref", "is-referenced-by-count": 10, "title": ["Efficacy and Tolerance of 5-Aminosalicylic Acid Suppositories in the Treatment of Ulcerative Proctitis: A Review of Two Double-Blind, Placebo Controlled Trials"], "prefix": "10.1155", "volume": "4", "author": [{"given": "CN", "family": "Williams", "sequence": "first", "affiliation": []}], "member": "98", "container-title": ["Canadian Journal of Gastroenterology"], "language": "en", "link": [{"URL": "http://downloads.hindawi.com/journals/cjgh/1990/689834.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://downloads.hindawi.com/journals/cjgh/1990/689834.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 8, 23]], "date-time": "2016-08-23T13:50:38Z", "timestamp": 1471960238000}, "score": 42.769955, "issued": {"date-parts": [[1990]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1990]]}, "issue": "7"}, "alternative-id": ["689834"], "URL": "http://dx.doi.org/10.1155/1990/689834", "ISSN": ["0835-7900"], "issn-type": [{"value": "0835-7900", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T22:55:45Z", "timestamp": 1575413745342}, "reference-count": 37, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Clinical Psychopharmacology"], "published-print": {"date-parts": [[2014, 2]]}, "DOI": "10.1097/jcp.0000000000000049", "type": "journal-article", "created": {"date-parts": [[2013, 12, 17]], "date-time": "2013-12-17T11:31:23Z", "timestamp": 1387279883000}, "page": "57-65", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Early Improvement in Depressive Symptoms With Desvenlafaxine 50 mg/d as a Predictor of Treatment Success in Patients With Major Depressive Disorder"], "prefix": "10.1097", "volume": "34", "author": [{"given": "Claudio N.", "family": "Soares", "sequence": "first", "affiliation": []}, {"given": "Rana S.", "family": "Fayyad", "sequence": "additional", "affiliation": []}, {"given": "Christine J.", "family": "Guico-Pabia", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Journal of Clinical Psychopharmacology"], "language": "en", "deposited": {"date-parts": [[2019, 8, 5]], "date-time": "2019-08-05T00:57:05Z", "timestamp": 1564966625000}, "score": 39.733994, "subtitle": [""], "issued": {"date-parts": [[2014, 2]]}, "references-count": 37, "journal-issue": {"issue": "1"}, "URL": "http://dx.doi.org/10.1097/jcp.0000000000000049", "ISSN": ["0271-0749"], "issn-type": [{"value": "0271-0749", "type": "print"}], "subject": ["Pharmacology (medical)", "Psychiatry and Mental health"]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T21:55:04Z", "timestamp": 1575237304053}, "reference-count": 0, "publisher": "Physicians Postgraduate Press, Inc", "issue": "06", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Clin. Psychiatry"], "published-print": {"date-parts": [[2013, 6, 15]]}, "DOI": "10.4088/jcp.12m08250", "type": "journal-article", "created": {"date-parts": [[2013, 6, 18]], "date-time": "2013-06-18T19:03:41Z", "timestamp": 1371582221000}, "page": "587-594", "source": "Crossref", "is-referenced-by-count": 39, "title": ["The Efficacy of Agomelatine in Elderly Patients With Recurrent Major Depressive Disorder"], "prefix": "10.4088", "volume": "74", "author": [{"given": "Reinhard", "family": "Heun", "sequence": "first", "affiliation": []}, {"given": "Antti", "family": "Ahokas", "sequence": "additional", "affiliation": []}, {"given": "Patrice", "family": "Boyer", "sequence": "additional", "affiliation": []}, {"given": "Natalia", "family": "Gim\u00e9nez-Montesinos", "sequence": "additional", "affiliation": []}, {"given": "Fernando", "family": "Pontes-Soares", "sequence": "additional", "affiliation": []}, {"given": "Val\u00e9rie", "family": "Olivier", "sequence": "additional", "affiliation": []}, {"name": "Agomelatine Study Group", "sequence": "additional", "affiliation": []}], "member": "2558", "container-title": ["The Journal of Clinical Psychiatry"], "deposited": {"date-parts": [[2013, 6, 18]], "date-time": "2013-06-18T19:03:45Z", "timestamp": 1371582225000}, "score": 38.19034, "subtitle": ["A Placebo-Controlled Study"], "issued": {"date-parts": [[2013, 6, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2013, 6, 15]]}, "issue": "06"}, "URL": "http://dx.doi.org/10.4088/jcp.12m08250", "ISSN": ["0160-6689"], "issn-type": [{"value": "0160-6689", "type": "print"}], "subject": ["Psychiatry and Mental health"]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T13:45:50Z", "timestamp": 1575553550398}, "reference-count": 132, "publisher": "Elsevier", "isbn-type": [{"value": "9780323581318", "type": "print"}], "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2020, 1, 1]], "date-time": "2020-01-01T00:00:00Z", "timestamp": 1577836800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2020]]}, "DOI": "10.1016/b978-0-323-58131-8.00003-3", "type": "book-chapter", "created": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T21:17:31Z", "timestamp": 1574457451000}, "page": "39-49", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Brain Structural Abnormalities of Major Depressive Disorder"], "prefix": "10.1016", "author": [{"given": "Hanjing", "family": "Wu", "sequence": "first", "affiliation": []}, {"given": "Tomas", "family": "Melicher", "sequence": "additional", "affiliation": []}, {"given": "Isabelle E.", "family": "Bauer", "sequence": "additional", "affiliation": []}, {"given": "Marsal", "family": "Sanches", "sequence": "additional", "affiliation": []}, {"given": "Jair C.", "family": "Soares", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Major Depressive Disorder"], "link": [{"URL": "https://api.elsevier.com/content/article/PII:B9780323581318000033?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:B9780323581318000033?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T21:18:31Z", "timestamp": 1574457511000}, "score": 34.126514, "issued": {"date-parts": [[2020]]}, "ISBN": ["9780323581318"], "references-count": 132, "URL": "http://dx.doi.org/10.1016/b978-0-323-58131-8.00003-3"}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T19:56:30Z", "timestamp": 1575402990135}, "reference-count": 25, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["NeuroReport"], "published-print": {"date-parts": [[2019, 3]]}, "DOI": "10.1097/wnr.0000000000001211", "type": "journal-article", "created": {"date-parts": [[2019, 2, 14]], "date-time": "2019-02-14T06:02:44Z", "timestamp": 1550124164000}, "page": "378-382", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Cerebral cortical thickness after treatment with desvenlafaxine succinate in major depressive disorder"], "prefix": "10.1097", "volume": "30", "author": [{"given": "Jee Su", "family": "Suh", "sequence": "first", "affiliation": []}, {"given": "Luciano", "family": "Minuzzi", "sequence": "additional", "affiliation": []}, {"given": "Lauren E.", "family": "Cudney", "sequence": "additional", "affiliation": []}, {"given": "William", "family": "Maich", "sequence": "additional", "affiliation": []}, {"given": "Maha", "family": "Eltayebani", "sequence": "additional", "affiliation": []}, {"given": "Claudio N.", "family": "Soares", "sequence": "additional", "affiliation": []}, {"given": "Benicio N.", "family": "Frey", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["NeuroReport"], "language": "en", "link": [{"URL": "http://journals.lww.com/neuroreport/Fulltext/10.1097/WNR.0000000000001211", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 28]], "date-time": "2019-02-28T20:56:29Z", "timestamp": 1551387389000}, "score": 34.11027, "subtitle": [""], "issued": {"date-parts": [[2019, 3]]}, "references-count": 25, "journal-issue": {"issue": "5"}, "URL": "http://dx.doi.org/10.1097/wnr.0000000000001211", "ISSN": ["0959-4965"], "issn-type": [{"value": "0959-4965", "type": "print"}], "subject": ["General Neuroscience"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T10:06:17Z", "timestamp": 1574157977588}, "reference-count": 0, "publisher": "American Medical Association (AMA)", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Arch Gen Psychiatry"], "published-print": {"date-parts": [[2001, 6, 1]]}, "DOI": "10.1001/archpsyc.58.6.529", "type": "journal-article", "created": {"date-parts": [[2003, 3, 18]], "date-time": "2003-03-18T16:45:16Z", "timestamp": 1048005916000}, "page": "529", "source": "Crossref", "is-referenced-by-count": 391, "title": ["Efficacy of Estradiol for the Treatment of Depressive Disorders in Perimenopausal Women"], "prefix": "10.1001", "volume": "58", "author": [{"given": "Cl\u00e1udio", "family": "de Novaes Soares", "sequence": "first", "affiliation": []}, {"given": "Osvaldo P.", "family": "Almeida", "sequence": "additional", "affiliation": []}, {"given": "Hadine", "family": "Joffe", "sequence": "additional", "affiliation": []}, {"given": "Lee S.", "family": "Cohen", "sequence": "additional", "affiliation": []}], "member": "10", "container-title": ["Archives of General Psychiatry"], "language": "en", "link": [{"URL": "http://jamanetwork.com/journals/jamapsychiatry/fullarticle/481788", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 17]], "date-time": "2016-12-17T01:32:56Z", "timestamp": 1481938376000}, "score": 33.645668, "subtitle": ["A Double-blind, Randomized, Placebo-Controlled Trial"], "issued": {"date-parts": [[2001, 6, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2001, 6, 1]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1001/archpsyc.58.6.529", "ISSN": ["0003-990X"], "issn-type": [{"value": "0003-990X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T09:28:16Z", "timestamp": 1574846896787}, "reference-count": 36, "publisher": "Wiley", "issue": "12", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2017, 10, 13]], "date-time": "2017-10-13T00:00:00Z", "timestamp": 1507852800000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://creativecommons.org/licenses/by-nc/4.0/", "start": {"date-parts": [[2017, 10, 13]], "date-time": "2017-10-13T00:00:00Z", "timestamp": 1507852800000}, "delay-in-days": 0, "content-version": "vor"}], "funder": [{"name": "BIAL - Portela & C\u00aa S.A.", "award": ["BIA-2093-301-302-303-304"]}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CNS Neurosci Ther"], "published-print": {"date-parts": [[2017, 12]]}, "DOI": "10.1111/cns.12765", "type": "journal-article", "created": {"date-parts": [[2017, 10, 14]], "date-time": "2017-10-14T04:36:42Z", "timestamp": 1507955802000}, "page": "961-972", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Pooled efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Data from four double-blind placebo-controlled pivotal phase III clinical studies"], "prefix": "10.1111", "volume": "23", "author": [{"given": "Christian", "family": "Elger", "sequence": "first", "affiliation": [{"name": "Department of Epileptology; University of Bonn; Bonn Germany"}]}, {"given": "Mathias", "family": "Koepp", "sequence": "additional", "affiliation": [{"name": "Department of Clinical and Experimental Epilepsy; Institute of Neurology; London UK"}]}, {"given": "Eugen", "family": "Trinka", "sequence": "additional", "affiliation": [{"name": "Department of Neurology; Christian Doppler Medical Centre and Centre for Cognitive Neuroscience; Paracelsus Medical University; Salzburg Austria"}]}, {"given": "Vicente", "family": "Villanueva", "sequence": "additional", "affiliation": [{"name": "Unidad Multidisciplinar de Epilepsia; Hospital Universitario y Polit\u00e9cnico La Fe; Valencia Spain"}]}, {"given": "Jo\u00e3o", "family": "Chaves", "sequence": "additional", "affiliation": [{"name": "Servi\u00e7o de Neurologia; Hospital S. Ant\u00f3nio; Centro Hospitalar do Porto; Porto Portugal"}]}, {"given": "Elinor", "family": "Ben-Menachen", "sequence": "additional", "affiliation": [{"name": "Department of Clinical Neuroscience and Physiology; Sahlgren Academy; Sahlgren University Hospital; G\u00f6teborg Sweden"}]}, {"given": "Pedro A.", "family": "Kowacs", "sequence": "additional", "affiliation": [{"name": "Curitiba Neurological Institute; Curitiba Brazil"}]}, {"given": "Ant\u00f3nio", "family": "Gil-Nagel", "sequence": "additional", "affiliation": [{"name": "Epilepsy Program; Hospital Ruber Internacional; Madrid Spain"}]}, {"given": "Joana", "family": "Moreira", "sequence": "additional", "affiliation": [{"name": "Department of Research and Development; BIAL - Portela & C\u00aa, S.A.; S. Mamede do Coronado Portugal"}]}, {"given": "Helena", "family": "Gama", "sequence": "additional", "affiliation": [{"name": "Department of Research and Development; BIAL - Portela & C\u00aa, S.A.; S. Mamede do Coronado Portugal"}]}, {"given": "Jos\u00e9-Francisco", "family": "Rocha", "sequence": "additional", "affiliation": [{"name": "Department of Research and Development; BIAL - Portela & C\u00aa, S.A.; S. Mamede do Coronado Portugal"}]}, {"ORCID": "http://orcid.org/0000-0002-2446-5078", "authenticated-orcid": false, "given": "Patr\u00edcio", "family": "Soares-da-Silva", "sequence": "additional", "affiliation": [{"name": "Department of Research and Development; BIAL - Portela & C\u00aa, S.A.; S. Mamede do Coronado Portugal"}, {"name": "Department of Biomedicine; Faculty of Medicine; Unit of Pharmacology and Therapeutics; University of Porto; Porto Portugal"}, {"name": "MedInUP - Center for Drug Discovery and Innovative Medicines; University of Porto; Porto Portugal"}]}], "member": "311", "published-online": {"date-parts": [[2017, 10, 13]]}, "reference": [{"key": "10.1111/cns.12765-BIB0001|cns12765-cit-0001", "doi-asserted-by": "crossref", "first-page": "278", "DOI": "10.1016/j.eplepsyres.2010.01.014", "article-title": "Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy", "volume": "89", "author": "Ben-Menachem", "year": "2010", "journal-title": "Epilepsy Res"}, {"key": "10.1111/cns.12765-BIB0002|cns12765-cit-0002", "doi-asserted-by": "crossref", "first-page": "454", "DOI": "10.1111/j.1528-1167.2008.01946.x", "article-title": "Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study", "volume": "50", "author": "Elger", "year": "2009", "journal-title": "Epilepsia"}, {"key": "10.1111/cns.12765-BIB0003|cns12765-cit-0003", "doi-asserted-by": "crossref", "first-page": "281", "DOI": "10.1111/j.1600-0404.2009.01218.x", "article-title": "Efficacy and safety of 800 and 1200\u00a0mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures", "volume": "120", "author": "Gil-Nagel", "year": "2009", "journal-title": "Acta Neurol Scand"}, {"key": "10.1111/cns.12765-BIB0004|cns12765-cit-0004", "doi-asserted-by": "crossref", "first-page": "244", "DOI": "10.1111/epi.12894", "article-title": "Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: results of a phase III, double-blind, randomized, placebo-controlled trial", "volume": "56", "author": "Sperling", "year": "2015", "journal-title": "Epilepsia"}, {"key": "10.1111/cns.12765-BIB0005|cns12765-cit-0005", "unstructured": "EMA CHMP Assessment Report for Zebinix http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/000988/WC500047229.pdf"}, {"key": "10.1111/cns.12765-BIB0006|cns12765-cit-0006", "doi-asserted-by": "crossref", "first-page": "98", "DOI": "10.1111/j.1528-1167.2012.03605.x", "article-title": "Efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: integrated analysis of pooled data from double-blind phase III clinical studies", "volume": "54", "author": "Gil-Nagel", "year": "2013", "journal-title": "Epilepsia"}, {"issue": "Suppl 1", "key": "10.1111/cns.12765-BIB0007|cns12765-cit-0007", "doi-asserted-by": "crossref", "first-page": "S66", "DOI": "10.1111/j.1528-1157.2000.tb02175.x", "article-title": "Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults", "volume": "41", "author": "Reife", "year": "2000", "journal-title": "Epilepsia"}, {"key": "10.1111/cns.12765-BIB0008|cns12765-cit-0008", "doi-asserted-by": "crossref", "first-page": "423", "DOI": "10.1016/S0920-1211(96)01007-8", "article-title": "Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 study group", "volume": "26", "author": "Brodie", "year": "1997", "journal-title": "Epilepsy Res"}, {"key": "10.1111/cns.12765-BIB0009|cns12765-cit-0009", "author": "Perucca", "first-page": "121", "year": "2009", "edition": "3", "volume-title": "The Treatment of Epilepsy"}, {"key": "10.1111/cns.12765-BIB0010|cns12765-cit-0010", "doi-asserted-by": "crossref", "first-page": "267", "DOI": "10.1007/s00228-007-0414-1", "article-title": "Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment", "volume": "64", "author": "Almeida", "year": "2008", "journal-title": "Eur J Clin Pharmacol"}, {"key": "10.1111/cns.12765-BIB0011|cns12765-cit-0011", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.5414/CPP46119", "article-title": "Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate", "volume": "46", "author": "Maia", "year": "2008", "journal-title": "Int J Clin Pharmacol Ther"}, {"key": "10.1111/cns.12765-BIB0012|cns12765-cit-0012", "author": "Almeida", "first-page": "485", "year": "2009", "edition": "3", "volume-title": "The Treatment of Epilepsy", "DOI": "10.1002/9781444316667.ch38", "doi-asserted-by": "crossref"}, {"key": "10.1111/cns.12765-BIB0013|cns12765-cit-0013", "doi-asserted-by": "crossref", "first-page": "966", "DOI": "10.1177/0091270008319706", "article-title": "Pharmacokinetics, efficacy, and tolerability of eslicarbazepine acetate in children and adolescents with epilepsy", "volume": "48", "author": "Almeida", "year": "2008", "journal-title": "J Clin Pharmacol"}, {"key": "10.1111/cns.12765-BIB0014|cns12765-cit-0014", "doi-asserted-by": "crossref", "first-page": "249", "DOI": "10.1002/bdd.549", "article-title": "Effect of gender on the pharmacokinetics of eslicarbazepine acetate (BIA 2-093), a new voltage-gated sodium channel blocker", "volume": "28", "author": "Falcao", "year": "2007", "journal-title": "Biopharm Drug Dispos"}, {"key": "10.1111/cns.12765-BIB0015|cns12765-cit-0015", "doi-asserted-by": "crossref", "first-page": "132", "DOI": "10.1016/j.eplepsyres.2011.05.013", "article-title": "Pharmacokinetics of eslicarbazepine acetate at steady-state in adults with partial-onset seizures", "volume": "96", "author": "Perucca", "year": "2011", "journal-title": "Epilepsy Res"}, {"key": "10.1111/cns.12765-BIB0016|cns12765-cit-0016", "doi-asserted-by": "crossref", "first-page": "600", "DOI": "10.1046/j.1528-1157.2001.43600.x", "article-title": "Interaction of the novel anticonvulsant, BIA 2-093, with voltage-gated sodium channels: comparison with carbamazepine", "volume": "42", "author": "Bonifacio", "year": "2001", "journal-title": "Epilepsia"}, {"key": "10.1111/cns.12765-BIB0017|cns12765-cit-0017", "doi-asserted-by": "crossref", "first-page": "122", "DOI": "10.1016/j.neuropharm.2014.09.008", "article-title": "Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide", "volume": "89", "author": "Hebeisen", "year": "2015", "journal-title": "Neuropharmacology"}, {"key": "10.1111/cns.12765-BIB0018|cns12765-cit-0018", "doi-asserted-by": "crossref", "first-page": "e00124", "DOI": "10.1002/prp2.124", "article-title": "Eslicarbazepine acetate for the treatment of focal epilepsy: an update on its proposed mechanisms of action", "volume": "3", "author": "Soares-da-Silva", "year": "2015", "journal-title": "Pharmacol Res Perspect"}, {"key": "10.1111/cns.12765-BIB0019|cns12765-cit-0019", "doi-asserted-by": "crossref", "first-page": "371", "DOI": "10.1093/brain/awu339", "article-title": "Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug", "volume": "138", "author": "Doeser", "year": "2015", "journal-title": "Brain"}, {"key": "10.1111/cns.12765-BIB0020|cns12765-cit-0020", "doi-asserted-by": "crossref", "first-page": "134", "DOI": "10.1186/s12868-014-0134-2", "article-title": "Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus", "volume": "15", "author": "Sierra-Paredes", "year": "2014", "journal-title": "BMC Neurosci"}, {"key": "10.1111/cns.12765-BIB0021|cns12765-cit-0021", "doi-asserted-by": "crossref", "first-page": "212", "DOI": "10.1016/j.eplepsyres.2013.11.017", "article-title": "Effect of eslicarbazepine acetate in the corneal kindling progression and the amygdala kindling model of temporal lobe epilepsy", "volume": "108", "author": "Potschka", "year": "2014", "journal-title": "Epilepsy Res"}, {"key": "10.1111/cns.12765-BIB0022|cns12765-cit-0022", "doi-asserted-by": "crossref", "first-page": "103", "DOI": "10.1016/j.neuropharm.2015.01.019", "article-title": "Carbamazepine and oxcarbazepine, but not eslicarbazepine, enhance excitatory synaptic transmission onto hippocampal CA1 pyramidal cells through an antagonist action at adenosine A1 receptors", "volume": "93C", "author": "Booker", "year": "2015", "journal-title": "Neuropharmacology"}, {"key": "10.1111/cns.12765-BIB0023|cns12765-cit-0023", "doi-asserted-by": "crossref", "first-page": "935", "DOI": "10.1111/j.1528-1167.2012.03519.x", "article-title": "Pharmacokinetics and drug interactions of eslicarbazepine acetate", "volume": "53", "author": "Bialer", "year": "2012", "journal-title": "Epilepsia"}, {"key": "10.1111/cns.12765-BIB0024|cns12765-cit-0024", "doi-asserted-by": "crossref", "first-page": "627", "DOI": "10.1016/j.yebeh.2004.07.004", "article-title": "What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?", "volume": "5", "author": "Schmidt", "year": "2004", "journal-title": "Epilepsy Behav"}, {"key": "10.1111/cns.12765-BIB0025|cns12765-cit-0025", "author": "Bialer", "first-page": "459", "year": "2002", "edition": "5", "volume-title": "Antiepileptic Drugs"}, {"key": "10.1111/cns.12765-BIB0026|cns12765-cit-0026", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.2165/00044011-200424040-00001", "article-title": "Overview of the clinical pharmacokinetics of oxcarbazepine", "volume": "24", "author": "Flesch", "year": "2004", "journal-title": "Clin Drug Investig"}, {"key": "10.1111/cns.12765-BIB0027|cns12765-cit-0027", "doi-asserted-by": "crossref", "first-page": "547", "DOI": "10.1053/cp.1999.v66.103170001", "article-title": "Enantioselective pharmacokinetics of 10-hydroxycarbazepine after oral administration of oxcarbazepine to healthy Chinese subjects", "volume": "66", "author": "Volosov", "year": "1999", "journal-title": "Clin Pharmacol Ther"}, {"key": "10.1111/cns.12765-BIB0028|cns12765-cit-0028", "doi-asserted-by": "crossref", "first-page": "1597", "DOI": "10.1111/j.1499-1654.2000.001597.x", "article-title": "Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy", "volume": "41", "author": "Barcs", "year": "2000", "journal-title": "Epilepsia"}, {"key": "10.1111/cns.12765-BIB0029|cns12765-cit-0029", "doi-asserted-by": "crossref", "first-page": "108", "DOI": "10.1111/j.1528-1167.2012.03595.x", "article-title": "Steady-state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers", "volume": "54", "author": "Nunes", "year": "2013", "journal-title": "Epilepsia"}, {"key": "10.1111/cns.12765-BIB0030|cns12765-cit-0030", "doi-asserted-by": "crossref", "first-page": "1453", "DOI": "10.1111/epi.12242", "article-title": "Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers", "volume": "54", "author": "Elger", "year": "2013", "journal-title": "Epilepsia"}, {"key": "10.1111/cns.12765-BIB0031|cns12765-cit-0031", "doi-asserted-by": "crossref", "first-page": "1292", "DOI": "10.1007/s00115-012-3598-2", "article-title": "Slow release versus immediate release oxcarbazepine in difficult-to-treat focal epilepsy: a multicenter, randomized, open, controlled, parallel group phase III study", "volume": "83", "author": "Steinhoff", "year": "2012", "journal-title": "Nervenarzt"}, {"key": "10.1111/cns.12765-BIB0032|cns12765-cit-0032", "doi-asserted-by": "crossref", "first-page": "528", "DOI": "10.1016/j.seizure.2013.03.016", "article-title": "Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine", "volume": "22", "author": "Zaccara", "year": "2013", "journal-title": "Seizure"}, {"key": "10.1111/cns.12765-BIB0033|cns12765-cit-0033", "doi-asserted-by": "crossref", "first-page": "410", "DOI": "10.1111/j.0013-9580.2004.06304.x", "article-title": "Efficacy and tolerability of the new antiepileptic drugs, II: treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American academy of neurology and the American epilepsy society", "volume": "45", "author": "French", "year": "2004", "journal-title": "Epilepsia"}, {"key": "10.1111/cns.12765-BIB0034|cns12765-cit-0034", "doi-asserted-by": "crossref", "first-page": "e00634", "DOI": "10.1002/brb3.634", "article-title": "Transition from oxcarbazepine to eslicarbazepine acetate: a single center study", "volume": "7", "author": "Makinen", "year": "2017", "journal-title": "Brain Behav"}, {"key": "10.1111/cns.12765-BIB0035|cns12765-cit-0035", "doi-asserted-by": "crossref", "first-page": "449", "DOI": "10.1111/ane.12645", "article-title": "Overnight switching from oxcarbazepine to eslicarbazepine acetate: an observational study", "volume": "135", "author": "Schmid", "year": "2017", "journal-title": "Acta Neurol Scand"}, {"key": "10.1111/cns.12765-BIB0036|cns12765-cit-0036", "doi-asserted-by": "crossref", "first-page": "421", "DOI": "10.1007/s00415-016-8338-2", "article-title": "Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies", "volume": "264", "author": "Shorvon", "year": "2017", "journal-title": "J Neurol"}], "container-title": ["CNS Neuroscience & Therapeutics"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fcns.12765", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://onlinelibrary.wiley.com/wol1/doi/10.1111/cns.12765/fullpdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 11, 4]], "date-time": "2017-11-04T11:46:20Z", "timestamp": 1509795980000}, "score": 32.460022, "issued": {"date-parts": [[2017, 10, 13]]}, "references-count": 36, "journal-issue": {"published-print": {"date-parts": [[2017, 12]]}, "issue": "12"}, "URL": "http://dx.doi.org/10.1111/cns.12765", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["1755-5930"], "issn-type": [{"value": "1755-5930", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T13:26:48Z", "timestamp": 1574342808172}, "reference-count": 36, "publisher": "Wiley", "issue": "2", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 2800, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Hum. Psychopharmacol. Clin. Exp."], "published-print": {"date-parts": [[2008, 3]]}, "DOI": "10.1002/hup.912", "type": "journal-article", "created": {"date-parts": [[2008, 1, 3]], "date-time": "2008-01-03T10:47:57Z", "timestamp": 1199357277000}, "page": "87-94", "source": "Crossref", "is-referenced-by-count": 164, "title": ["Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study"], "prefix": "10.1002", "volume": "23", "author": [{"given": "Fabiano G.", "family": "Nery", "sequence": "first", "affiliation": []}, {"given": "Emel S.", "family": "Monkul", "sequence": "additional", "affiliation": []}, {"given": "John P.", "family": "Hatch", "sequence": "additional", "affiliation": []}, {"given": "Manoela", "family": "Fonseca", "sequence": "additional", "affiliation": []}, {"given": "Giovana B.", "family": "Zunta-Soares", "sequence": "additional", "affiliation": []}, {"given": "Ben\u00edcio N.", "family": "Frey", "sequence": "additional", "affiliation": []}, {"given": "Charles L.", "family": "Bowden", "sequence": "additional", "affiliation": []}, {"given": "Jair C.", "family": "Soares", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2008]]}, "reference": [{"key": "10.1002/hup.912-BIB1", "author": "Abdel-Halim", "volume": "43", "first-page": "266", "year": "1978", "journal-title": "Acta Pharmacol Toxicol", "DOI": "10.1111/j.1600-0773.1978.tb02264.x", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB2", "author": "Akhondzadeh", "volume": "90", "first-page": "179", "year": "2007", "journal-title": "Schizophr Res", "DOI": "10.1016/j.schres.2006.11.016", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB3", "author": "Calabrese", "volume": "17", "first-page": "41", "year": "1986", "journal-title": "Psychiatry Res", "DOI": "10.1016/0165-1781(86)90040-5", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB4", "author": "Casolini", "volume": "68", "first-page": "337", "year": "2002", "journal-title": "J Neurosci Res", "DOI": "10.1002/jnr.10192", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB5", "author": "Chang", "volume": "77", "first-page": "796", "year": "2001", "journal-title": "J Neurochem", "DOI": "10.1046/j.1471-4159.2001.00311.x", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB6", "author": "Dantzer", "volume": "15", "first-page": "7", "year": "2001", "journal-title": "Brain Behav Immun", "DOI": "10.1006/brbi.2000.0613", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB7", "author": "Ellenberg", "volume": "30", "first-page": "535", "year": "1996", "journal-title": "Drug Inf J", "DOI": "10.1177/009286159603000229", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB8", "author": "Faries", "volume": "34", "first-page": "3", "year": "2000", "journal-title": "J Psychiatr Res", "DOI": "10.1016/S0022-3956(99)00037-0", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB9", "author": "First", "year": "2000", "unstructured": ", , . 2000. Structured Clinical Interview for DSM-IV-TR Axis I Disorders. State Psychiatric Institute, Biometrics Research: Department: New York, NY.", "volume-title": "Structured Clinical Interview for DSM-IV-TR Axis I Disorders"}, {"key": "10.1002/hup.912-BIB10", "author": "Fitzgerald", "volume": "345", "first-page": "433", "year": "2001", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJM200108093450607", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB11", "author": "Gershon", "volume": "54", "first-page": "16", "year": "1997", "journal-title": "Arch Gen Psychiatry", "DOI": "10.1001/archpsyc.1997.01830130020004", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB12", "author": "Hamilton", "first-page": "179", "year": "1976", "unstructured": "1976. Hamilton Psychiatric Rating Scale for Depression. In ECDEU Assessment Manual for Psychopharmacology, (ed). U.S. Department of Health, Education and Welfare: Washington DC; 179\u2013192.", "volume-title": "ECDEU Assessment Manual for Psychopharmacology"}, {"key": "10.1002/hup.912-BIB13", "author": "Hu", "volume": "10", "first-page": "426", "year": "2005", "journal-title": "Mol Psychiatry", "DOI": "10.1038/sj.mp.4001644", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB14", "author": "ICH Steering Committee", "year": "1998", "unstructured": "ICH Steering Committee. (5 February 1998). ICH harmonized tripartite guideline: statistical principles for clinical trials (E9). International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Available at http://www.ich.org/cache/compo/276-254-1. html Accessed May 12, 2007."}, {"key": "10.1002/hup.912-BIB15", "author": "Kleven", "volume": "42", "first-page": "1155", "year": "1983", "journal-title": "Fed Proc"}, {"key": "10.1002/hup.912-BIB16", "author": "Lieb", "volume": "10", "first-page": "361", "year": "1983", "journal-title": "Prostaglandins Leukot Med", "DOI": "10.1016/0262-1746(83)90048-3", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB17", "author": "Lingjaerde", "volume": "334", "first-page": "1", "year": "1978", "journal-title": "Acta Psychiatr Scand"}, {"key": "10.1002/hup.912-BIB18", "author": "Linnoila", "volume": "40", "first-page": "405", "year": "1983", "journal-title": "Arch Gen Psychiatry", "DOI": "10.1001/archpsyc.1983.01790040059008", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB19", "author": "Little", "year": "1987", "unstructured": ". 1987. Statistical Analysis With Missing Data. John Wiley & Sons: New York.", "volume-title": "Statistical Analysis With Missing Data"}, {"key": "10.1002/hup.912-BIB20", "author": "Mirjany", "volume": "301", "first-page": "494", "year": "2002", "journal-title": "J Pharmacol Exp Ther", "DOI": "10.1124/jpet.301.2.494", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB21", "author": "Muller", "volume": "159", "first-page": "1029", "year": "2002", "journal-title": "Am J Psychiatry", "DOI": "10.1176/appi.ajp.159.6.1029", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB22", "author": "Muller", "volume": "11", "first-page": "680", "year": "2006", "journal-title": "Mol Psychiatry", "DOI": "10.1038/sj.mp.4001805", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB23", "author": "Nierenberg", "volume": "163", "first-page": "210", "year": "2006", "journal-title": "Am J Psychiatry", "DOI": "10.1176/appi.ajp.163.2.210", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB24", "author": "Nishino", "volume": "146", "first-page": "365", "year": "1989", "journal-title": "Am J Psychiatry", "DOI": "10.1176/ajp.146.12.1647", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB25", "author": "Raison", "volume": "27", "first-page": "24", "year": "2006", "journal-title": "Trends Immunol", "DOI": "10.1016/j.it.2005.11.006", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB26", "author": "Rapaport", "volume": "57", "first-page": "1594", "year": "2005", "journal-title": "Biol Psychiatry", "DOI": "10.1016/j.biopsych.2005.02.024", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB27", "author": "Ross", "volume": "450", "first-page": "141", "year": "2002", "journal-title": "Eur J Pharmacol", "DOI": "10.1016/S0014-2999(02)02104-0", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB28", "author": "Sachs", "volume": "356", "first-page": "1711", "year": "2007", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJMoa064135", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB29", "author": "Sandrini", "volume": "51", "first-page": "154", "year": "2002", "journal-title": "Inflamm Res", "DOI": "10.1007/PL00000287", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB30", "author": "Schulz", "volume": "359", "first-page": "781", "year": "2002", "journal-title": "Lancet", "DOI": "10.1016/S0140-6736(02)07882-0", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB31", "author": "Soares", "volume": "15", "first-page": "183", "year": "2000", "journal-title": "Int Clin Psychopharmacol", "DOI": "10.1097/00004850-200015040-00001", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB32", "author": "Strauss", "volume": "19", "first-page": "627", "year": "2002", "journal-title": "J Neurotrauma", "DOI": "10.1089/089771502753754091", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB33", "author": "Trivedi", "volume": "66", "first-page": "1064", "year": "2005", "journal-title": "J Clin Psychiatry", "DOI": "10.4088/JCP.v66n0816", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB34", "author": "Vickers", "volume": "323", "first-page": "1123", "year": "2001", "journal-title": "BMJ", "DOI": "10.1136/bmj.323.7321.1123", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB35", "author": "Yatham", "volume": "7", "first-page": "5", "year": "2005", "journal-title": "Bipolar Disord", "DOI": "10.1111/j.1399-5618.2005.00219.x", "doi-asserted-by": "crossref"}, {"key": "10.1002/hup.912-BIB36", "author": "Young", "volume": "133", "first-page": "429", "year": "1978", "journal-title": "Br J Psychiatry", "DOI": "10.1192/bjp.133.5.429", "doi-asserted-by": "crossref"}], "container-title": ["Human Psychopharmacology: Clinical and Experimental"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhup.912", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/hup.912", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 6]], "date-time": "2019-02-06T21:22:24Z", "timestamp": 1549488144000}, "score": 32.343254, "issued": {"date-parts": [[2008]]}, "references-count": 36, "journal-issue": {"published-print": {"date-parts": [[2008, 3]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1002/hup.912", "relation": {"cites": []}, "ISSN": ["0885-6222", "1099-1077"], "issn-type": [{"value": "0885-6222", "type": "print"}, {"value": "1099-1077", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T07:42:04Z", "timestamp": 1574494924315}, "reference-count": 29, "publisher": "Springer Science and Business Media LLC", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CNS Drugs"], "published-print": {"date-parts": [[2011, 3]]}, "DOI": "10.2165/11586460-000000000-00000", "type": "journal-article", "created": {"date-parts": [[2011, 2, 17]], "date-time": "2011-02-17T08:19:55Z", "timestamp": 1297930795000}, "page": "227-238", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Open-Label Treatment with Desvenlafaxine in Postmenopausal Women with Major Depressive Disorder Not Responding to Acute Treatment with Desvenlafaxine or Escitalopram"], "prefix": "10.1007", "volume": "25", "author": [{"given": "Claudio N.", "family": "Soares", "sequence": "first", "affiliation": []}, {"given": "Michael E.", "family": "Thase", "sequence": "additional", "affiliation": []}, {"given": "Anita", "family": "Clayton", "sequence": "additional", "affiliation": []}, {"given": "Christine J.", "family": "Guico-Pabia", "sequence": "additional", "affiliation": []}, {"given": "Kristen", "family": "Focht", "sequence": "additional", "affiliation": []}, {"given": "Qin", "family": "Jiang", "sequence": "additional", "affiliation": []}, {"given": "Susan G.", "family": "Kornstein", "sequence": "additional", "affiliation": []}, {"given": "Phillip T.", "family": "Ninan", "sequence": "additional", "affiliation": []}, {"given": "Cecelia P.", "family": "Kane", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"issue": "1-3", "key": "R1-5-20110217", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1016/j.jad.2006.02.010", "volume": "93", "author": "Pinto-Meza", "year": "2006 Mar", "journal-title": "J Affect Disord"}, {"issue": "7", "key": "R2-5-20110217", "doi-asserted-by": "crossref", "first-page": "609", "DOI": "10.1089/jwh.2005.14.609", "volume": "14", "author": "Thase", "year": "2005 Sep", "journal-title": "J Womens Health"}, {"issue": "4", "key": "R3-5-20110217", "doi-asserted-by": "crossref", "first-page": "405", "DOI": "10.1097/01.jcp.0000085415.08426.c6", "volume": "23", "author": "Grigoriadis", "year": "2003", "journal-title": "J Clin Psychopharmacol"}, {"issue": "2", "key": "R4-5-20110217", "doi-asserted-by": "crossref", "first-page": "657", "DOI": "10.1124/jpet.106.103382", "volume": "318", "author": "Deecher", "year": "2006", "journal-title": "J Pharmacol Exp Ther"}, {"key": "R6-5-20110217", "author": "Riederer", "volume": "247", "first-page": "IV/36", "year": "2000", "journal-title": "J Neurol"}, {"issue": "4", "key": "R7-5-20110217", "doi-asserted-by": "crossref", "first-page": "828", "DOI": "10.1097/gme.0b013e3181d770a8", "volume": "17", "author": "Kornstein", "year": "2010", "journal-title": "Menopause"}, {"issue": "4", "key": "R8-5-20110217", "first-page": "700", "volume": "17", "author": "Soares", "year": "2010", "journal-title": "Menopause"}, {"key": "R9-5-20110217", "author": "Hamilton", "volume": "23", "first-page": "56", "year": "1960 Feb", "journal-title": "J Neurol Neurosurg Psychiatry", "DOI": "10.1136/jnnp.23.1.56", "doi-asserted-by": "crossref"}, {"key": "R10-5-20110217", "author": "Sheehan", "volume": "59", "first-page": "22", "year": "1998", "journal-title": "the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 J Clin Psychiatry"}, {"key": "R11-5-20110217", "author": "Benagiano", "volume": "997", "first-page": "163", "year": "2003", "journal-title": "Ann N Y Acad Sci", "DOI": "10.1196/annals.1290.019", "doi-asserted-by": "crossref"}, {"key": "R12-5-20110217", "author": "Montgomery", "volume": "134", "first-page": "382", "year": "1979", "journal-title": "Br J Psychiatry", "DOI": "10.1192/bjp.134.4.382", "doi-asserted-by": "crossref"}, {"key": "R13-5-20110217", "author": "Guy", "first-page": "217", "year": "1976"}, {"issue": "3", "key": "R14-5-20110217", "doi-asserted-by": "crossref", "first-page": "169", "DOI": "10.1016/S0163-8343(97)00016-9", "volume": "19", "author": "Katon", "year": "1997", "journal-title": "Gen Hosp Psychiatry"}, {"issue": "1", "key": "R15-5-20110217", "doi-asserted-by": "crossref", "first-page": "50", "DOI": "10.1111/j.2044-8341.1959.tb00467.x", "volume": "32", "author": "Hamilton", "year": "1959", "journal-title": "Br J Med Psychol"}, {"issue": "5", "key": "R16-5-20110217", "doi-asserted-by": "crossref", "first-page": "573", "DOI": "10.1016/S0006-3223(02)01866-8", "volume": "54", "author": "Rush", "year": "2003", "journal-title": "Biol Psychiatry"}, {"issue": "1", "key": "R17-5-20110217", "doi-asserted-by": "crossref", "first-page": "102", "DOI": "10.1097/00000539-199801000-00020", "volume": "86", "author": "DeLoach", "year": "1998", "journal-title": "Anesth Analg"}, {"issue": "4", "key": "R18-5-20110217", "first-page": "731", "volume": "33", "author": "Clayton", "year": "1997", "journal-title": "Psychopharmacol Bull"}, {"key": "R20-5-20110217", "author": "Heinemann", "volume": "2", "first-page": "45", "year": "2004", "journal-title": "Health Qual Life Outcomes", "DOI": "10.1186/1477-7525-2-45", "doi-asserted-by": "crossref"}, {"key": "R21-5-20110217", "author": "Sheehan", "first-page": "113", "year": "2000"}, {"issue": "2", "key": "R22-5-20110217", "doi-asserted-by": "crossref", "first-page": "100", "DOI": "10.1080/13651500802578975", "volume": "13", "author": "Romera", "year": "2009", "journal-title": "Int J Psychiatry Clin Pract"}, {"issue": "5", "key": "R23-5-20110217", "doi-asserted-by": "crossref", "first-page": "401", "DOI": "10.1097/00004714-199910000-00003", "volume": "19", "author": "de Montigny", "year": "1999", "journal-title": "J Clin Psychopharmacol"}, {"issue": "4", "key": "R24-5-20110217", "doi-asserted-by": "crossref", "first-page": "483", "DOI": "10.1097/00004714-200008000-00014", "volume": "20", "author": "Mitchell", "year": "2000", "journal-title": "J Clin Psychopharmacol"}, {"issue": "3", "key": "R25-5-20110217", "doi-asserted-by": "crossref", "first-page": "250", "DOI": "10.1097/01.jcp.0000219922.19305.08", "volume": "26", "author": "Thase", "year": "2006", "journal-title": "J Clin Psychopharmacol"}, {"issue": "12", "key": "R26-5-20110217", "doi-asserted-by": "crossref", "first-page": "1231", "DOI": "10.1056/NEJMoa052963", "volume": "354", "author": "Rush", "year": "2006", "journal-title": "N Engl J Med"}, {"issue": "6", "key": "R27-5-20110217", "doi-asserted-by": "crossref", "first-page": "552", "DOI": "10.1097/01.jcp.0000185429.10053.c8", "volume": "25", "author": "Wohlreich", "year": "2005", "journal-title": "J Clin Psychopharmacol"}, {"issue": "1", "key": "R28-5-20110217", "doi-asserted-by": "crossref", "first-page": "95", "DOI": "10.4088/JCP.v69n0113", "volume": "69", "author": "Perahia", "year": "2008", "journal-title": "J Clin Psychiatry"}, {"issue": "3", "key": "R29-5-20110217", "doi-asserted-by": "crossref", "first-page": "405", "DOI": "10.1093/ajcn/70.3.405", "volume": "70", "author": "Guo", "year": "1999", "journal-title": "Am J Clin Nutr"}, {"issue": "7", "key": "R30-5-20110217", "doi-asserted-by": "crossref", "first-page": "1681", "DOI": "10.1111/j.1743-6109.2008.00838.x", "volume": "5", "author": "Hayes", "year": "2008", "journal-title": "J Sex Med"}, {"issue": "5", "key": "R31-5-20110217", "doi-asserted-by": "crossref", "first-page": "324", "DOI": "10.1097/01.nmd.0000217820.33841.53", "volume": "194", "author": "Posternak", "year": "2006", "journal-title": "J Nerv Ment Dis"}], "container-title": ["CNS Drugs"], "language": "en", "deposited": {"date-parts": [[2019, 6, 8]], "date-time": "2019-06-08T16:11:38Z", "timestamp": 1560010298000}, "score": 31.703817, "subtitle": [""], "issued": {"date-parts": [[2011, 3]]}, "references-count": 29, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.2165/11586460-000000000-00000", "relation": {"cites": []}, "ISSN": ["1172-7047"], "issn-type": [{"value": "1172-7047", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T06:59:44Z", "timestamp": 1575442784659}, "reference-count": 45, "publisher": "Cambridge University Press (CUP)", "issue": "6", "license": [{"URL": "https://www.cambridge.org/core/terms", "start": {"date-parts": [[2014, 2, 26]], "date-time": "2014-02-26T00:00:00Z", "timestamp": 1393372800000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CNS Spectr."], "published-print": {"date-parts": [[2014, 12]]}, "abstract": "<jats:sec id=\"S1092852914000066_abs1\" sec-type=\"general\"><jats:title>Background</jats:title><jats:p>The predictive value of early functional improvement for treatment success at week 8 was assessed in a pooled analysis in patients with major depressive disorder (MDD).</jats:p></jats:sec><jats:sec id=\"S1092852914000066_abs2\" sec-type=\"methods\"><jats:title>Methods</jats:title><jats:p>Data were pooled from 7 double-blind studies in adult patients with MDD randomly assigned to desvenlafaxine 50 mg/d or placebo. Four levels of treatment success were determined at week 8 for patients with baseline Sheehan Disability Scale (SDS) score &gt; 12 (N = 2156): <jats:italic>functional response</jats:italic> (SDS \u226412 and \u226550% improvement in SDS), <jats:italic>functional/depression response</jats:italic> (SDS \u226412 and \u226550% improvement in both SDS and 17-item Hamilton Rating Scale for Depression [HAM-D<jats:sub>17</jats:sub>] score), <jats:italic>functional remission</jats:italic> (SDS &lt; 7), and <jats:italic>functional/depression remission</jats:italic> (SDS &lt; 7 and HAM-D<jats:sub>17</jats:sub> \u22647). Week 2 improvement in SDS was evaluated as a predictor of later functional response/remission using receiver operating characteristic analysis. Odds ratios (ORs) of the predictability of improvement thresholds were computed from a logistic regression model.</jats:p></jats:sec><jats:sec id=\"S1092852914000066_abs3\" sec-type=\"results\"><jats:title>Results</jats:title><jats:p>The proportion of patients achieving each level of treatment success was significantly greater for patients treated with desvenlafaxine (40%, 32%, 23%, 15%, respectively) vs placebo (31%, 22%, 17%, 10%; all <jats:italic>P</jats:italic> \u2264 0.002). Early change in SDS was a highly significant predictor of functional response/remission (ORs, 0.958\u20130.970; all <jats:italic>P</jats:italic> &lt; 0.0001).</jats:p></jats:sec><jats:sec id=\"S1092852914000066_abs4\" sec-type=\"discussion\"><jats:title>Discussion</jats:title><jats:p>Patients\u2019 early functional response to desvenlafaxine 50 mg/d is predictive of treatment success.</jats:p></jats:sec>", "DOI": "10.1017/s1092852914000066", "type": "journal-article", "created": {"date-parts": [[2014, 2, 26]], "date-time": "2014-02-26T13:43:38Z", "timestamp": 1393422218000}, "page": "519-527", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Predictors of functional response and remission with desvenlafaxine 50 mg/d in patients with major depressive disorder"], "prefix": "10.1017", "volume": "19", "author": [{"given": "Claudio N.", "family": "Soares", "sequence": "first", "affiliation": []}, {"given": "Jean", "family": "Endicott", "sequence": "additional", "affiliation": []}, {"given": "Matthieu", "family": "Boucher", "sequence": "additional", "affiliation": []}, {"given": "Rana S.", "family": "Fayyad", "sequence": "additional", "affiliation": []}, {"given": "Christine J.", "family": "Guico-Pabia", "sequence": "additional", "affiliation": []}], "member": "56", "published-online": {"date-parts": [[2014, 2, 26]]}, "reference": [{"key": "S1092852914000066_ref21", "author": "Sheehan", "first-page": "113", "year": "2000", "volume-title": "Handbook of Psychiatric Measures"}, {"key": "S1092852914000066_ref33", "DOI": "10.1016/j.jad.2009.06.041", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref45", "DOI": "10.1186/1471-244X-13-94", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref24", "unstructured": "World Medical Association. World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. World Medical Association. http://www.wma.net/en/30publications/10policies/b3/17c.pdf. Accessed October 7, 2013."}, {"key": "S1092852914000066_ref18", "DOI": "10.1016/S0163-8343(00)00072-4", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref2", "DOI": "10.1192/bjp.134.4.382", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref17", "DOI": "10.1001/jama.289.23.3135", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref14", "DOI": "10.1046/j.1524-4733.2003.00148.x", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref1", "DOI": "10.1136/jnnp.23.1.56", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref23", "DOI": "10.1097/JCP.0000000000000049", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref12", "first-page": "S316", "article-title": "Major depressive disorder: psychosocial impairment and key considerations in functional improvement", "volume": "15", "author": "Papakostas", "year": "2009", "journal-title": "Am J Manag Care"}, {"key": "S1092852914000066_ref30", "unstructured": "World Health Organization. Wellbeing measures in primary health care/the depcare project. World Health Organization Regional Office for Europe. http://www.euro.who.int/__data/assets/pdf_file/0016/130750/E60246.pdf. Accessed October 7, 2013."}, {"key": "S1092852914000066_ref6", "DOI": "10.1002/gps.2261", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref20", "DOI": "10.1002/da.20505", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref32", "DOI": "10.1097/YIC.0b013e3282f2b4d6", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref37", "DOI": "10.4088/JCP.9104su1c.03", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref4", "DOI": "10.4088/JCP.v64n0410", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref42", "DOI": "10.1097/YIC.0b013e32830cebed", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref22", "first-page": "S328", "article-title": "Functional outcomes in MDD: established and emerging assessment tools", "volume": "15", "author": "Endicott", "year": "2009", "journal-title": "Am J Manag Care"}, {"key": "S1092852914000066_ref34", "unstructured": "Work Group on Major Depressive Disorder. Practice guideline for the treatment of patients with major depressive disorder. American Psychiatric Association. http://www.psychiatryonline.com/pracGuide/pracGuideTopic_7.aspx. Accessed October 7, 2013."}, {"key": "S1092852914000066_ref36", "DOI": "10.1016/j.jad.2008.10.011", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref13", "DOI": "10.1097/YIC.0b013e3283277614", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref9", "DOI": "10.1016/S0006-3223(01)01291-4", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref8", "unstructured": "World Health Organization. The World Health Report 2001: Mental health: new understanding, new hope. http://www.who.int/whr/2001/en/whr01_en.pdf. Accessed October 7, 2013."}, {"key": "S1092852914000066_ref15", "DOI": "10.1016/S0163-8343(03)00018-5", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref16", "DOI": "10.1097/JOM.0b013e31828349c9", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref27", "DOI": "10.4088/JCP.12m08065", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref11", "DOI": "10.2165/00023210-200519040-00004", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref43", "DOI": "10.1016/j.clinthera.2009.07.006", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref29", "first-page": "69", "article-title": "Differentiating anxiety and depression in anxiety disorders: use of rating scales", "volume": "18", "author": "Lipman", "year": "1982", "journal-title": "Psychopharmacol Bull"}, {"key": "S1092852914000066_ref41", "DOI": "10.1185/03007990802161923", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref35", "first-page": "166", "article-title": "Early improvements in anxiety, depression, and anger/hostility symptoms and response to antidepressant treatment", "volume": "22", "author": "Farabaugh", "year": "2010", "journal-title": "Ann Clin Psychiatry"}, {"key": "S1092852914000066_ref3", "DOI": "10.1097/00004714-199512000-00006", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref5", "DOI": "10.4088/JCP.07m03780", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref10", "DOI": "10.4088/JCP.v61n0405", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref28", "DOI": "10.1097/JCP.0b013e31822c0a68", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref40", "DOI": "10.1176/appi.ajp.2012.12020250", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref31", "first-page": "115", "article-title": "Factor analysis of the Hamilton depression scale", "volume": "1", "author": "Cleary", "year": "1977", "journal-title": "Drugs Exp Clin Res"}, {"key": "S1092852914000066_ref19", "DOI": "10.1097/YIC.0b013e32834c2488", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref39", "DOI": "10.1176/ajp.2006.163.9.1569", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref25", "year": "1994", "volume-title": "Diagnostic and Statistical Manual of Mental Disorders"}, {"key": "S1092852914000066_ref38", "author": "Gallop", "first-page": "777", "year": "2001", "volume-title": "Proceedings of the NorthEast SAS Users Group"}, {"key": "S1092852914000066_ref7", "DOI": "10.1097/JCP.0b013e318210856f", "doi-asserted-by": "publisher"}, {"key": "S1092852914000066_ref26", "year": "2000", "volume-title": "Diagnostic and Statistical Manual of Mental Disorders"}, {"key": "S1092852914000066_ref44", "DOI": "10.1097/01.pra.0000426323.59698.64", "doi-asserted-by": "publisher"}], "container-title": ["CNS Spectrums"], "language": "en", "link": [{"URL": "https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S1092852914000066", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 21]], "date-time": "2019-04-21T22:04:37Z", "timestamp": 1555884277000}, "score": 31.519741, "issued": {"date-parts": [[2014, 2, 26]]}, "references-count": 45, "journal-issue": {"published-print": {"date-parts": [[2014, 12]]}, "issue": "6"}, "alternative-id": ["S1092852914000066"], "URL": "http://dx.doi.org/10.1017/s1092852914000066", "relation": {"cites": []}, "ISSN": ["1092-8529", "2165-6509"], "issn-type": [{"value": "1092-8529", "type": "print"}, {"value": "2165-6509", "type": "electronic"}], "subject": ["Psychiatry and Mental health", "Clinical Neurology"]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T21:46:10Z", "timestamp": 1575495970039}, "update-to": [{"updated": {"date-parts": [[2019, 8, 6]], "date-time": "2019-08-06T00:00:00Z", "timestamp": 1565049600000}, "DOI": "10.29328/journal.apmh.1001007", "type": "new_edition", "label": "New edition"}], "reference-count": 0, "publisher": "Heighten Science Publications Corporation", "issue": "1", "content-domain": {"domain": ["www.heighpubs.org"], "crossmark-restriction": true}, "short-container-title": ["Arch Psychiatr Ment Health"], "DOI": "10.29328/journal.apmh.1001007", "type": "journal-article", "created": {"date-parts": [[2019, 8, 13]], "date-time": "2019-08-13T08:06:15Z", "timestamp": 1565683575000}, "page": "025-031", "update-policy": "http://dx.doi.org/10.29328/crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Effectiveness of low dose Ethinylestradiol/Cyproterone Acetate, Ethinylestradiol/Desogestrel and metformin on hirsutism, hormonal and metabolic parameters of patients with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled study"], "prefix": "10.29328", "volume": "3", "author": [{"given": "S", "family": "Fonseka", "sequence": "first", "affiliation": []}, {"given": "B", "family": "Subhani", "sequence": "additional", "affiliation": []}, {"given": "V", "family": "Alahakoon", "sequence": "additional", "affiliation": []}, {"given": "CN", "family": "Wijeyaratne", "sequence": "additional", "affiliation": []}, {"given": "IB", "family": "Gawarammana", "sequence": "additional", "affiliation": []}], "member": "11877", "published-online": {"date-parts": [[2019, 8, 6]]}, "container-title": ["Archives of Psychiatry and Mental Health"], "deposited": {"date-parts": [[2019, 8, 13]], "date-time": "2019-08-13T08:06:17Z", "timestamp": 1565683577000}, "score": 31.303059, "issued": {"date-parts": [[2019, 8, 6]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2019]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.29328/journal.apmh.1001007"}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T03:55:27Z", "timestamp": 1574740527107}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2015, 10, 1]], "date-time": "2015-10-01T00:00:00Z", "timestamp": 1443657600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of the Neurological Sciences"], "published-print": {"date-parts": [[2015, 10]]}, "DOI": "10.1016/j.jns.2015.08.993", "type": "journal-article", "created": {"date-parts": [[2015, 11, 2]], "date-time": "2015-11-02T12:05:38Z", "timestamp": 1446465938000}, "page": "e284-e285", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Opicapone\u2019s efficacy in Parkinson\u2019s disease patients with motor fluctuations: a phase III, randomized, double-blind, placebo and active-controlled study \u2013 bipark I study"], "prefix": "10.1016", "volume": "357", "author": [{"given": "J.", "family": "Ferreira", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Lees", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Rocha", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Santos", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Lopes", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Soares-da-Silva", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Journal of the Neurological Sciences"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0022510X15014896?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0022510X15014896?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 18]], "date-time": "2018-09-18T03:56:11Z", "timestamp": 1537242971000}, "score": 30.96567, "issued": {"date-parts": [[2015, 10]]}, "references-count": 0, "alternative-id": ["S0022510X15014896"], "URL": "http://dx.doi.org/10.1016/j.jns.2015.08.993", "ISSN": ["0022-510X"], "issn-type": [{"value": "0022-510X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T05:42:28Z", "timestamp": 1574487748321}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "Meeting Abstracts 1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neurology"], "published-print": {"date-parts": [[2012, 4, 26]]}, "DOI": "10.1212/wnl.78.1_meetingabstracts.p06.104", "type": "journal-article", "created": {"date-parts": [[2012, 7, 11]], "date-time": "2012-07-11T23:11:45Z", "timestamp": 1342048305000}, "page": "P06.104-P06.104", "source": "Crossref", "is-referenced-by-count": 1, "title": ["An Investigation of the Incidence and Time to Onset of Adverse Events Associated with Eslicarbazepine Acetate Adjunct Treatment: An Integrated Analysis of Two Double-Blind Placebo-Controlled Trials (P06.104)"], "prefix": "10.1212", "volume": "78", "author": [{"given": "M.", "family": "Sperling", "sequence": "first", "affiliation": []}, {"given": "T.", "family": "Grinnell", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Versavel", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Zummo", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Blum", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Soares-da-Silva", "sequence": "additional", "affiliation": []}], "member": "276", "published-online": {"date-parts": [[2012, 4, 22]]}, "container-title": ["Neurology"], "language": "en", "deposited": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T20:05:55Z", "timestamp": 1518206755000}, "score": 30.891914, "issued": {"date-parts": [[2012, 4, 22]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2012, 4, 22]]}, "published-print": {"date-parts": [[2012, 4, 22]]}, "issue": "Meeting Abstracts 1"}, "URL": "http://dx.doi.org/10.1212/wnl.78.1_meetingabstracts.p06.104", "ISSN": ["0028-3878", "1526-632X"], "issn-type": [{"value": "0028-3878", "type": "print"}, {"value": "1526-632X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T06:44:42Z", "timestamp": 1574318682605}, "reference-count": 0, "publisher": "Physicians Postgraduate Press, Inc", "issue": "8", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Clin. Psychiatry"], "published-print": {"date-parts": [[2008, 8, 15]]}, "DOI": "10.4088/jcp.v69n0806", "type": "journal-article", "created": {"date-parts": [[2009, 8, 21]], "date-time": "2009-08-21T18:30:53Z", "timestamp": 1250879453000}, "page": "1237-1245", "source": "Crossref", "is-referenced-by-count": 69, "title": ["A Double-Blind, Randomized, Placebo-Controlled 4-Week Study on the Efficacy and Safety of the Purinergic Agents Allopurinol and Dipyridamole Adjunctive to Lithium in Acute Bipolar Mania"], "prefix": "10.4088", "volume": "69", "author": [{"given": "Rodrigo", "family": "Machado-Vieira", "sequence": "first", "affiliation": []}, {"given": "Jair C.", "family": "Soares", "sequence": "additional", "affiliation": []}, {"given": "Diogo R.", "family": "Lara", "sequence": "additional", "affiliation": []}, {"given": "David A.", "family": "Luckenbaugh", "sequence": "additional", "affiliation": []}, {"given": "Jo\u00e3o V.", "family": "Busnello", "sequence": "additional", "affiliation": []}, {"given": "Getulio", "family": "Marca", "sequence": "additional", "affiliation": []}, {"given": "Angelo", "family": "Cunha", "sequence": "additional", "affiliation": []}, {"given": "Diogo O.", "family": "Souza", "sequence": "additional", "affiliation": []}, {"suffix": "Jr.", "given": "Carlos A.", "family": "Zarate", "sequence": "additional", "affiliation": []}, {"given": "Falvio", "family": "Kapczinski", "sequence": "additional", "affiliation": []}], "member": "2558", "container-title": ["The Journal of Clinical Psychiatry"], "deposited": {"date-parts": [[2011, 8, 17]], "date-time": "2011-08-17T06:09:36Z", "timestamp": 1313561376000}, "score": 29.996862, "issued": {"date-parts": [[2008, 8, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2008, 8, 15]]}, "issue": "8"}, "URL": "http://dx.doi.org/10.4088/jcp.v69n0806", "ISSN": ["0160-6689"], "issn-type": [{"value": "0160-6689", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T04:40:33Z", "timestamp": 1574138433723}, "reference-count": 23, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Psychosomatic Medicine"], "published-print": {"date-parts": [[2004, 9]]}, "DOI": "10.1097/01.psy.0000140005.94790.9c", "type": "journal-article", "created": {"date-parts": [[2004, 9, 22]], "date-time": "2004-09-22T18:32:58Z", "timestamp": 1095877978000}, "page": "707-713", "source": "Crossref", "is-referenced-by-count": 47, "title": ["Paroxetine Controlled Release for Premenstrual Dysphoric Disorder: A Double-Blind, Placebo-Controlled Trial"], "prefix": "10.1097", "volume": "66", "author": [{"given": "Lee S.", "family": "Cohen", "sequence": "first", "affiliation": []}, {"given": "Claudio N.", "family": "Soares", "sequence": "additional", "affiliation": []}, {"given": "Kimberly A.", "family": "Yonkers", "sequence": "additional", "affiliation": []}, {"given": "Kevin M.", "family": "Bellew", "sequence": "additional", "affiliation": []}, {"given": "Ian M.", "family": "Bridges", "sequence": "additional", "affiliation": []}, {"given": "Meir", "family": "Steiner", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Psychosomatic Medicine"], "language": "en", "deposited": {"date-parts": [[2018, 8, 5]], "date-time": "2018-08-05T19:37:04Z", "timestamp": 1533497824000}, "score": 29.528994, "subtitle": [""], "issued": {"date-parts": [[2004, 9]]}, "references-count": 23, "journal-issue": {"issue": "5"}, "URL": "http://dx.doi.org/10.1097/01.psy.0000140005.94790.9c", "ISSN": ["0033-3174"], "issn-type": [{"value": "0033-3174", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T06:41:39Z", "timestamp": 1575182499080}, "reference-count": 15, "publisher": "S. Karger AG", "issue": "6", "license": [{"URL": "https://www.karger.com/Services/SiteLicenses", "start": {"date-parts": [[2005, 1, 1]], "date-time": "2005-01-01T00:00:00Z", "timestamp": 1104537600000}, "delay-in-days": 0, "content-version": "vor"}, {"URL": "https://www.karger.com/Services/SiteLicenses", "start": {"date-parts": [[2005, 1, 1]], "date-time": "2005-01-01T00:00:00Z", "timestamp": 1104537600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Psychother Psychosom"], "published-print": {"date-parts": [[2005]]}, "DOI": "10.1159/000087783", "type": "journal-article", "created": {"date-parts": [[2005, 10, 19]], "date-time": "2005-10-19T10:43:33Z", "timestamp": 1129718613000}, "page": "362-365", "source": "Crossref", "is-referenced-by-count": 13, "title": ["Antidepressant Response and Well-Being in Pre-, Peri- and Postmenopausal Women with Major Depressive Disorder Treated with Fluoxetine"], "prefix": "10.1159", "volume": "74", "author": [{"given": "Paolo", "family": "Cassano", "sequence": "first", "affiliation": []}, {"given": "Claudio N.", "family": "Soares", "sequence": "additional", "affiliation": []}, {"given": "Cristina", "family": "Cusin", "sequence": "additional", "affiliation": []}, {"given": "Alessandra", "family": "Mascarini", "sequence": "additional", "affiliation": []}, {"given": "Lee S.", "family": "Cohen", "sequence": "additional", "affiliation": []}, {"given": "Maurizio", "family": "Fava", "sequence": "additional", "affiliation": []}], "member": "127", "published-online": {"date-parts": [[2005, 10, 19]]}, "reference": [{"key": "sref_1_447", "author": "Kornstein SG", "volume": "157", "first-page": "1445", "year": "2000", "journal-title": "Am J Psychiatry", "DOI": "10.1176/appi.ajp.157.9.1445", "doi-asserted-by": "crossref"}, {"key": "sref_2_448", "author": "Quitkin FM", "volume": "159", "first-page": "1848", "year": "2002", "journal-title": "Am J Psychiatry", "DOI": "10.1176/appi.ajp.159.11.1848", "doi-asserted-by": "crossref"}, {"key": "sref_3_449", "author": "Salmaggi P", "volume": "59", "first-page": "34", "year": "1993", "journal-title": "Psychother Psychosom", "DOI": "10.1159/000288642", "doi-asserted-by": "crossref"}, {"key": "sref_4_450", "unstructured": "Entsuah AR, Cantillon M, Thase ME: Venalfaxine and SSRIs in the treatment of depression: Comparison among age and gender variables (poster). Am Coll Neuropsychopharmacol Annu Meet, Hawaii, December 2001."}, {"key": "sref_5_451", "author": "Soares CN", "volume": "58", "first-page": "529", "year": "2001", "journal-title": "Arch Gen Psychiatry", "DOI": "10.1001/archpsyc.58.6.529", "doi-asserted-by": "crossref"}, {"key": "sref_6_452", "DOI": "10.1067/mob.2000.106004", "doi-asserted-by": "publisher"}, {"key": "sref_7_453", "author": "Amsterdam J", "volume": "55", "first-page": "11", "year": "1999", "journal-title": "J Affect Disord", "DOI": "10.1016/S0165-0327(98)00203-1", "doi-asserted-by": "crossref"}, {"key": "sref_8_454", "author": "Martenyi F", "volume": "11", "first-page": "227", "year": "2001", "journal-title": "Eur Neuropsychopharmacol", "DOI": "10.1016/S0924-977X(01)00089-X", "doi-asserted-by": "crossref"}, {"key": "sref_9_455", "author": "Fava M", "volume": "42", "first-page": "568", "year": "1997", "journal-title": "Biol Psychiatry", "DOI": "10.1016/S0006-3223(96)00440-4", "doi-asserted-by": "crossref"}, {"key": "sref_10_456", "author": "Spitzer RL", "volume": "49", "first-page": "624", "year": "1992", "journal-title": "Arch Gen Psychiatry", "DOI": "10.1001/archpsyc.1992.01820080032005", "doi-asserted-by": "crossref"}, {"key": "sref_11_457", "author": "Kellner R", "volume": "48", "first-page": "268", "year": "1987", "journal-title": "J Clin Psychiatry"}, {"key": "sref_12_458", "author": "O'Sullivan RL", "volume": "95", "first-page": "379", "year": "1997", "journal-title": "Acta Psychiatr Scand", "DOI": "10.1111/j.1600-0447.1997.tb09649.x", "doi-asserted-by": "crossref"}, {"key": "sref_13_459", "DOI": "10.1097/00004714-200210000-00006", "doi-asserted-by": "publisher"}, {"key": "sref_14_460", "author": "Cassano P", "volume": "7", "first-page": "167", "year": "2004", "journal-title": "Arch Women Ment Health", "DOI": "10.1007/s00737-004-0051-y", "doi-asserted-by": "crossref"}, {"key": "sref_15_461", "author": "Aubuchon M", "volume": "59", "first-page": "22", "year": "2004", "journal-title": "Geriatrics"}], "container-title": ["Psychotherapy and Psychosomatics"], "language": "en", "link": [{"URL": "https://www.karger.com/Article/Pdf/87783", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://www.karger.com/Article/Pdf/87783", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 19]], "date-time": "2019-03-19T04:45:40Z", "timestamp": 1552970740000}, "score": 28.889143, "issued": {"date-parts": [[2005]]}, "references-count": 15, "journal-issue": {"published-online": {"date-parts": [[2005, 10, 1]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1159/000087783", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0033-3190", "1423-0348"], "issn-type": [{"value": "0033-3190", "type": "print"}, {"value": "1423-0348", "type": "electronic"}], "subject": ["Applied Psychology", "Clinical Psychology", "Psychiatry and Mental health", "General Medicine"]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}